Norbolethone: Difference between revisions
m (Protected "Norbolethone": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
| Line 1: | Line 1: | ||
{{drugbox | | {{drugbox | | ||
| Line 38: | Line 38: | ||
{{reflist}} | {{reflist}} | ||
{{Anabolic steroids}} | {{Anabolic steroids}} | ||
[[Category:Anabolic steroids]] | [[Category:Anabolic steroids]] | ||
Revision as of 14:23, 20 August 2012
| Error creating thumbnail: File missing | |
| Clinical data | |
|---|---|
| Synonyms | Norbolethone, Genabol |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C21H32O2 |
| Molar mass | 316.47758 g/mol |
|
WikiDoc Resources for Norbolethone |
|
Articles |
|---|
|
Most recent articles on Norbolethone Most cited articles on Norbolethone |
|
Media |
|
Powerpoint slides on Norbolethone |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Norbolethone at Clinical Trials.gov Clinical Trials on Norbolethone at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Norbolethone
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Norbolethone Discussion groups on Norbolethone Patient Handouts on Norbolethone Directions to Hospitals Treating Norbolethone Risk calculators and risk factors for Norbolethone
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Norbolethone |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Norbolethone (Genabol) is an anabolic steroid. It was first developed in 1966, and tested for use as an agent to encourage weight gain and for the treatment of short stature, but was never marketed commercially. It subsequently showed up in urine tests on athletes in competition in the early 2000s.[1]
Norbolethone was found to have been brought to the market by the chemist Patrick Arnold, of the Bay Area Laboratory Co-operative (BALCO), an American nutritional supplement company. It is reputed to have been the active ingredient in the original formulation of the "undetectable" steroid formulation known as "The Clear" before being replaced by the more potent drug tetrahydrogestrinone.[2][3]
References
- ↑ Catlin DH, Ahrens BD, Kucherova Y. Detection of norbolethone, an anabolic steroid never marketed, in athletes' urine. Rapid Communications in Mass Spectrometry. 2002;16(13):1273-5.
- ↑ "Chemist Who Created "The Clear" Sentenced" (Press release). United States Attorney for the Northern District of California. 2006-08-04. Retrieved 2007-10-08.
- ↑ Knight J. Drugs bust reveals athletes' secret steroid. Nature. 2003 Oct 23;425(6960):752.
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Anabolic steroids
- Endocrinology